Trademark: 90532971
Word
ONCOREVEAL
Status
Pending
Status Code
807
Status Date
Friday, March 8, 2024
Serial Number
90532971
Mark Type
4000
Filing Date
Wednesday, February 17, 2021
Published for Opposition
Tuesday, December 7, 2021

Trademark Owner History
Pillar Biosciences, Inc. - Owner At Publication

Classifications
35 Data processing services for medical, clinical, and scientific purposes
44 Providing biological sample testing services for others in the field of medical diagnostics; providing biological sample testing services for others for medical purposes, namely, for the diagnosis and treatment of cancer; providing reagent sample testing and diagnostic services for others, namely, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the field of medical diagnostics; genetic testing for medical and clinical medical purposes; medical testing for diagnostic and treatment purposes; consulting services for medical and clinical medical purposes, health and wellness assessment services; providing health and wellness information
42 Software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for collecting, managing, and analyzing data in the fields of scientific research, clinical research, scientific diagnostics, and medical diagnostics; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for analyzing biological samples; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for analyzing biological samples for medical purposes, namely, for the diagnosis and treatment of cancer; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others with reagents and reagent kits, all for the purpose of detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, scientific diagnostics research, and medical diagnostics; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for bioinformatics and gene expression microarray image analysis, namely, gene expression quantification, gene image processing, and gene information processing; software as a service (SaaS), namely, hosting non-downloadable computer software for health and wellness assessment, namely, for genomic analysis; software as a service (SaaS), namely, hosting non-downloadable computer software for genetic and bioinformatics analysis; bioinformatics services, namely, product research and development in the field of bioinformatics; data processing services for medical, clinical, and scientific purposes; developing diagnostic testing models for others for medical, clinical, and scientific purposes; Genetic testing for scientific research purposes; Scientific consulting relating to scientific research
ONCO REVEAL

Trademark Events
Mar 8, 2024
Notification Of Non-Final Action E-Mailed
Mar 8, 2024
Non-Final Action E-Mailed
Mar 8, 2024
Su - Non-Final Action - Written
Feb 6, 2024
Divisional Processing Complete
Jan 30, 2024
Divisional Request Received
Feb 6, 2024
Teas/Email Correspondence Entered
Jan 31, 2024
Correspondence Received In Law Office
Jan 31, 2024
Teas Response To Office Action Received
Jan 31, 2024
Teas Response To Office Action Received
Jan 30, 2024
Teas Request To Divide Received
Oct 30, 2023
Application Extension Granted/Receipt Provided
Oct 30, 2023
Application Extension To Response Period - Received
Jul 31, 2023
Notification Of Non-Final Action E-Mailed
Jul 31, 2023
Non-Final Action E-Mailed
Jul 31, 2023
Su - Non-Final Action - Written
Jul 7, 2023
Teas/Email Correspondence Entered
Jul 7, 2023
Correspondence Received In Law Office
Jul 7, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 7, 2023
Assigned To Lie
Mar 8, 2023
Teas Response To Office Action Received
Mar 8, 2023
Teas Change Of Correspondence Received
Mar 8, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Mar 8, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 8, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 8, 2022
Notification Of Non-Final Action E-Mailed
Sep 8, 2022
Non-Final Action E-Mailed
Sep 8, 2022
Su - Non-Final Action - Written
Aug 11, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 10, 2022
Statement Of Use Processing Complete
Aug 1, 2022
Use Amendment Filed
Aug 10, 2022
Sou Extension 1 Granted
Aug 1, 2022
Sou Extension 1 Filed
Aug 10, 2022
Case Assigned To Intent To Use Paralegal
Aug 1, 2022
Sou Teas Extension Received
Aug 1, 2022
Teas Statement Of Use Received
Feb 1, 2022
Noa E-Mailed - Sou Required From Applicant
Dec 7, 2021
Official Gazette Publication Confirmation E-Mailed
Dec 7, 2021
Published For Opposition
Nov 17, 2021
Notification Of Notice Of Publication E-Mailed
Nov 1, 2021
Approved For Pub - Principal Register
Nov 1, 2021
Examiner's Amendment Entered
Nov 1, 2021
Notification Of Examiners Amendment E-Mailed
Nov 1, 2021
Examiners Amendment E-Mailed
Nov 1, 2021
Examiners Amendment -Written
Oct 29, 2021
Previous Allowance Count Withdrawn
Oct 19, 2021
Withdrawn From Pub - Og Review Query
Oct 7, 2021
Approved For Pub - Principal Register
Oct 1, 2021
Teas/Email Correspondence Entered
Sep 30, 2021
Correspondence Received In Law Office
Sep 30, 2021
Teas Response To Office Action Received
Sep 21, 2021
Notification Of Non-Final Action E-Mailed
Sep 21, 2021
Non-Final Action E-Mailed
Sep 21, 2021
Non-Final Action Written
Sep 11, 2021
Assigned To Examiner
May 21, 2021
New Application Office Supplied Data Entered
Feb 23, 2021
Teas Amendment Entered Before Attorney Assigned
Feb 23, 2021
Teas Voluntary Amendment Received
Feb 20, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24